Article

Agnarelli, Alessandro, Lauer Betran, Andrea, Papakyriakou, Athanasios, Vella, Viviana, Samuels, Mark, Papanastasopoulos, Panagiotis, Giamas, Christina, Mancini, Erika J, Stebbing, Justin, Spencer, John, Cilibrasi, Chiara, Ditsiou, Angeliki and Giamas, Georgios (2023) The inhibitory properties of a novel, selective LMTK3 kinase inhibitor. International Journal of Molecular Sciences, 24 (1). e865 1-15. ISSN 1661-6596

Agnarelli, Alessandro, Vella, Viviana, Samuels, Mark, Papanastasopoulos, Panagiotis and Giamas, Georgios (2022) Incorporating immunotherapy in the management of gastric cancer: molecular and clinical implications. Cancers, 14 (18). e4378 1-25. ISSN 2072-6694

Vella, Viviana, Giamas, Georgios and Ditsiou, Angeliki (2021) Diving into the dark kinome: lessons learned from LMTK3. Cancer Gene Therapy. ISSN 0929-1903

Ditsiou, Angeliki, Gagliano, Teresa, Samuels, Mark, Vella, Viviana, Tolias, Christos and Giamas, Georgios (2021) The multifaceted role of lemur tyrosine kinase 3 in health and disease. Open biology, 11 (9). pp. 1-12. ISSN 2046-2441

Ditsiou, Angeliki, Cilibrasi, Chiara, Simigdala, Nikiana, Harris, Leanne, Vella, Viviana, Gagliano, Teresa, Iachini, Maria Chiara, Simon, Thomas, Zhou, Lihong, Hassell-Hart, Storm, Pearl, Laurence H, Roe, S Mark, Spencer, John, Prodromou, Chrisostomos, Giamas, Georgios and others, (2020) The structure-function relationship of oncogenic LMTK3. Science Advances, 6 (46). pp. 1-19. ISSN 2375-2548

Bresciani, Giulia, Ditsiou, Angeliki, Cilibrasi, Chiara, Vella, Viviana, Rea, Federico, Schiavon, Marco, Cavallesco, Narciso Giorgio, Giamas, Georgios, Zatelli, Maria Chiara and Gagliano, Teresa (2019) EGF and IGF1 affect Sunitinib activity in BP-NEN: new putative targets beyond VEGFR? Endocrine Connections, 8 (6). pp. 680-690. ISSN 2049-3614

Conference or Workshop Item

Bresciani, Giulia, Ditsiou, Angeliki, Cilibrasi, Chiara, Vella, Viviana, Rea, Federico, Schiavon, Marco, Cavallesco, Narciso Giorgio, Giamas, Georgios, Zatelli, Maria Chiara and Gagliano, Teresa (2019) EGFR and IGF1R affect Sunitinib activity: novel targets for Broncho-Pulmonary Neuroendocrine Neoplasm treatment. In: 21st European Congress of Endocrinology, 18th May - 21st May 2019, Lyon, France.